14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.50 $2.22 Friday, 3rd May 2024 OCUP stock ended at $1.99. This is 7.57% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 9.68% from a day low at $1.86 to a day high of $2.04.
90 days $1.50 $2.77
52 weeks $1.50 $6.60

Historical Ocuphire Pharma, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $1.94 $2.04 $1.86 $1.99 350 246
May 02, 2024 $1.67 $1.99 $1.65 $1.85 662 461
May 01, 2024 $1.63 $1.66 $1.59 $1.64 43 131
Apr 30, 2024 $1.65 $1.69 $1.57 $1.59 35 876
Apr 29, 2024 $1.61 $1.71 $1.61 $1.65 82 314
Apr 26, 2024 $1.55 $1.63 $1.55 $1.61 113 234
Apr 25, 2024 $1.52 $1.56 $1.50 $1.54 109 497
Apr 24, 2024 $1.52 $1.56 $1.50 $1.53 89 811
Apr 23, 2024 $1.51 $1.58 $1.51 $1.54 140 421
Apr 22, 2024 $1.64 $1.64 $1.50 $1.51 378 583
Apr 19, 2024 $1.67 $1.69 $1.59 $1.66 234 805
Apr 18, 2024 $1.77 $1.78 $1.67 $1.67 239 099
Apr 17, 2024 $1.74 $1.78 $1.74 $1.74 92 405
Apr 16, 2024 $1.74 $1.79 $1.71 $1.74 113 618
Apr 15, 2024 $1.86 $1.86 $1.74 $1.76 196 937
Apr 12, 2024 $1.82 $1.89 $1.71 $1.84 467 162
Apr 11, 2024 $1.84 $1.87 $1.77 $1.79 224 974
Apr 10, 2024 $1.90 $1.91 $1.83 $1.86 172 741
Apr 09, 2024 $1.83 $1.89 $1.83 $1.86 83 736
Apr 08, 2024 $1.93 $1.93 $1.83 $1.83 284 244
Apr 05, 2024 $1.93 $1.94 $1.83 $1.91 272 059
Apr 04, 2024 $2.00 $2.04 $1.86 $1.88 334 309
Apr 03, 2024 $2.14 $2.22 $1.90 $1.94 474 994
Apr 02, 2024 $2.24 $2.33 $2.14 $2.18 723 398
Apr 01, 2024 $2.02 $2.23 $2.02 $2.23 687 394
Click to get the best stock tips daily for free!

About Ocuphire Pharma, Inc.

Ocuphire Pharma. Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induc... OCUP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT